Chemtrade (CHE-U) sold off nearly 20% after announcing its rezoning application was rejected, putting a significant amount of chlor-alkali production beyond 2030 at risk…

… which would materially impact EBITDA, with management citing a ~$17M earnings hit from previous three week turnarounds at the facility. While a full shutdown would hurt less than that implies ($295M)…

… given associated overhead wouldn’t be there, the market now has to price the probability of a resolution and the impairment in a no-go scenario - which should be the main focus on CHE’s next earnings call.

About Bullpen: Bullpen Finance Inc. publishes content on Canadian markets and provides paid research coverage of select Canadian issuers. Bullpen is paid in cash by covered issuers, does not accept stock or options, does not hold positions in covered securities, and does not conduct investment banking business. Bullpen and LodeRock Advisors Inc. are affiliated; LodeRock provides investor relations services to issuers, some of whom are covered by Bullpen Research. When a post discusses a covered issuer, a specific disclosure appears at the top of the post. This post is published for general information purposes. It is not personalized investment advice and is not tailored to any individual reader’s circumstances. Bullpen is not a registered investment adviser or dealer. For full disclosures, including analyst certification, jurisdictional statements, and conflict of interest policies, please see our Legal & Disclosures section on our website.

You might be interested in…